Centinel Spine’s Total Disc Replacement System Soars: 2,500 U.S. Procedures in Record Time

Centinel Spine

WEST CHESTER, PA ā€”Ā Centinel SpineĀ®, LLC,Ā  recentlyĀ announced the completion of the 2,500thĀ case in the U.S. with the prodisc C VivoĀ and prodisc C SKĀ Cervical TDR System.

The prodisc C VivoĀ and prodisc C SKĀ technologies are part of the new Match-the-Discā„¢ System made available by the Company in a limited release in Q4 2022. Over 350 surgeons have used the new system over the last 12 months, validating the benefits of intraoperatively selecting the ideal implant for each patient’s anatomy. Nearly 70% of the surgeon users are repeat users and the new system is allowing the Company to significantly accelerate competitive conversions and increase utilization within its user base. The 2,500 procedure milestone comes just five months after the 1,000thĀ case was announced inĀ April 2023.

According toĀ Benjamin Geddes, orthopedic spine surgeon with the Center for Sports Medicine and Orthopedics,Ā Chattanooga, TN, “The ‘Match-the-Disc’ prodisc C VivoĀ and prodisc C SKĀ systemĀ provides multiple implant options to best fit each patient’s anatomy, while at the same time not creating extra instrumentation complexity. This increases your options as a surgeon while not bogging down your staff. There have been multiple occasions where I went in thinking I would use one prodiscĀ implant and in real time pivoted to a different prodiscĀ implant with better fit. This was done seamlessly without wasting valuable OR time.”

“The prodisc C VivoĀ and prodisc C SKĀ Match-the-Disc system has enabled Centinel Spine to push forward in its mission to be a catalyst of change in the spine market,” observes Centinel Spine CEOĀ Steve Murray. “Achieving this milestone so rapidly underscores surgeons’ receptivity towards the change that these new prodiscĀ systems bring to the spine operating room, as well as expansion of the total disc replacement market.”

READ:  Centinel Spine Surges to Record Revenue in First Quarter 2024, Leads Spine Industry Growth

The prodiscĀ portfolio is the most extensive TDR system in the world, offering both cervical and lumbar implants with anatomically-differentiated designs. Centinel Spine is the only company with FDA approval for both cervical and lumbar TDR systems. All of the prodiscĀ cervical and lumbar devices incorporate prodisc COREĀ technology, the basis behind the predictable clinical outcomes of the prodiscĀ platform after 30 years and over 250,000 implantations worldwide.*

  • Data on file with Centinel Spine.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.